Skip to main content
PMC home page
Evidence-based Complementary and Alternative Medicine : eCAM logoLink to Evidence-based Complementary and Alternative Medicine : eCAM
. 2012 Oct 24;2012:476457. doi: 10.1155/2012/476457

Effects of Electroacupuncture of Different Frequencies on the Release Profile of Endogenous Opioid Peptides in the Central Nerve System of Goats

Li-Li Cheng 1, Ming-Xing Ding 1,*, Cheng Xiong 1, Min-Yan Zhou 1, Zheng-Ying Qiu 1, Qiong Wang 1
PMCID: PMC3486625  PMID: 23133494

Abstract

To investigate the release profile of met-enkephalin, β-endorphin, and dynorphin-A in ruminants' CNS, goats were stimulated by electroacupuncture of 0, 2, 40, 60, 80, or 100 Hz for 30 min. The pain threshold was measured using potassium iontophoresis. The peptide levels were determined with SABC immunohistochemisty. The results showed that 60 Hz increased pain threshold by 91%; its increasing rate was higher (P < 0.01) than any other frequency did. 2 Hz and 100 Hz increased met-enkephalin immunoactivities (P < 0.05) in nucleus accumbens, septal area, caudate nucleus, amygdala, paraventricular nucleus of hypothalamus, periaqueductal gray, dorsal raphe nucleus, and locus ceruleus. The two frequencies elicited β-endorphin release (P < 0.05) in nucleus accumbens, septal area, supraoptic nucleus, ventromedial nucleus of hypothalamus, periaqueductal gray, dorsal raphe nucleus, locus ceruleus, solitary nucleus and amygdala. 60 Hz increased (P < 0.05) met-enkephalin or β-endorphin immunoactivities in the nuclei and areas mentioned above, and habenular nucleus, substantia nigra, parabrachial nucleus, and nucleus raphe magnus. High frequencies increased dynorphin-A release (P < 0.05) in spinal cord dorsal horn and most analgesia-related nuclei. It suggested that 60 Hz induced the simultaneous release of the three peptides in extensive analgesia-related nuclei and areas of the CNS, which may be contributive to optimal analgesic effects and species variation.

1. Introduction

Acupuncture is a traditional therapeutic technique in Oriental medicine, which has a long history of 4000 years. As a modern version of hand acupuncture, electroacupuncture (EA) can provide a valid analgesic effect and has little physiological interference [1, 2]. It was successfully used to ameliorate pain not only in varieties of painful diseases [3, 4], but in various operations, such as cesarean section, gastrectomy, enterectomy, and castration, in animals during the 1970s [1, 5]. Since then, analgesia-regulating mechanism of EA has been extensively investigated. Previous studies found that electroacupuncture analgesia (EAA) was involved in modulations of neurotransmitters or neuromodulators in the central nerve system (CNS) [6], and most early studies focused on the role of neurotransmitters such as serotonin, noradrenaline, dopamine, and acetylcholine. Later, it was certified that some endogenous opioid peptides (EOPs), mainly including enkephalin, β-endorphin, and dynorphin, played a more important role in EAA [7, 8]. EA of different frequencies can promote the release of different EOPs in the CNS. Studies showed that EAA induced by 2 Hz (low frequency) was mediated by the release of met-enkephalin (M-ENK) and β-endorphin (β-EP), while EAA by 100 Hz (high frequency) was mediated by the release of dynorphin-A (DYN-A) in the CNS in rats [9–11]. Although these results in rats above are extrapolated to give reasonable explanations for acupuncture analgesia phenomenon and its treatment of related diseases in human, there are still some unknown mechanisms to be investigated.

It has been proved that analgesia induced by EA varies in animal species. In order to quantitatively estimate the degree of acupuncture-induced analgesia, some researchers used an anesthetic to ensure a complete analgesia and to assess the reduction of the amount of the anesthetics consumed in the EA plus anesthetic group as compared to the anesthetic group without acupuncture. Studies showed that EA in combination with anesthetics resulted in the reduction of the dosage of the anesthetics in human, rat, and goat by 45%–55%, 50%–60%, and over 75%, respectively [12, 13]. It is clear that the analgesic effect induced by EA in goats (ruminants) is superior to that in rats or human. Therefore, the modalities of EOP release elicited by different frequencies in ruminants could be different from those in rats. In the present study, goats were stimulated with EA of different frequencies to determine the analgesic efficacy and the release levels of M-ENK, β-EP, and DYN-A in the CNS in order to probe into the mechanisms of EA-induced analgesia in ruminants.

2. Materials and Methods

2.1. Animal Preparation

Forty-nine healthy 1- to 2-year-old hybrid male goats, weighing 23–28 kg, were purchased from the goat farm of Hubei Agricultural Academy of Science. All experimental goats were randomly divided into seven groups of seven each, maintained on dry grass diet which was supplemented with a cereal-based concentrate, and drank freely. They were dewormed and accustomed to being approached. Feed was withheld for 24 h before the start of the experiment. The experiment was performed in a quiet environment, and the ambient temperature fluctuated between 23°C and 24°C. The experimental protocol was approved by the Animal Care Center, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China.

2.2. Electroacupuncture

A set of Baihui (hundred meetings), Santai (three platforms), Ergen (ear base), and Sanyangluo (three Yang communications) points was selected for EA. The anatomic location of these points has been described in detail in veterinary medicine [12, 14]. Needle insertion and EA were conducted with the method reported by Liu et al. [12]. Experimental animals were restrained in right recumbency, and stimulated with EA at 0, 2, 40, 60, 80, or 100 Hz for 30 min via WQ-6F Electronic Acupunctoscope (Beijing Xindonghua Electronic Instrument Co., Ltd., Beijing, China). The goats which were only dealt with needles left in the acupoints without electricity were used as the sham control.

2.3. Determination of Pain Threshold

Just before and after EA, the pain threshold was measured on the center of the left flank using the method of potassium iontophoresis [12, 15, 16]. The region used to measure pain threshold was shaved, cleaned with soap and water, and sterilized with 75% alcohol. Two electrodes soaked with saturated potassium chloride were placed 3 cm apart on the skin in position. A galvanofaradism apparatus (Shantou Medical Equipment Factory Co., Ltd., Shantou, China) was used to deliver pulsed direct current to the electrodes. The voltage was increased stepwise. Obvious contraction of the local skin and muscle was taken as the endpoint; the current was then terminated, and the volt level was recorded. The procedure was repeated three times. The average volt level was obtained. Mean voltages before and after EA were expressed as Vo and Vn, respectively. The change of percentage in pain threshold was calculated as follows: ∆(%) = (Vn–Vo)/Vo × 100%.

2.4. Measurements of the Levels of Endogenous Opioid Peptides

The levels of M-ENK, β-EP, and DYN-A were measured through the method of SABC immunohistochemisty. The nuclei were identified according to the photographic atlas of the goat brain, and the morphological characteristics of the neurons [17–19].

Once the pain threshold was measured after EA, the goats were deeply anesthesized with intravenous administration of xylidinothiazoline at 3 mg/kg. Physiological saline was infused through bilateral carotid arteries at the same velocity with which the blood bled out from the jugular veins for about 5 min (until the blood fluid became colorless). Four percent paraformaldehyde instead of the physiological saline was infused for about 1 h. The brain and a part of the adjacent spinal cord were taken out of the skull and cervical vertebral canal. The brain was placed on a paraffin plate with the ventral surface up. Then it was transected into seven sections through the caudal edge of the residual part of the olfactory bulbs, the center of the optic chiasm, the caudal edge of the mamillary body, the sulcus between cerebral peduncles and pons, the sulcus between pons and medulla oblongata, and the caudal borderline between medulla oblongata and spinal cord, respectively. The first section with the residual part of the olfactory bulbs was discarded. The others were put into 4% paraformaldehyde to fix for 48 h. The cerebral cortex and cerebellum were stripped with the amygdala region left. Each of the second to fourth sections was evenly cut into three subsections (S1 to S9), while the fifth and the sixth sections were averagely divided into two and five subsections (S10 to S16), respectively. The seventh section was just spinal cord (S17). The sectionalization of the brain and the localization of nuclei and areas in subsections were illustrated in Figure 1. Each of the subsections was embedded in a paraffin block, sectioned at 5 μm, mounted on polylysine-coated slides, deparaffinized, and rehydrated sequentially.

Figure 1.

Figure 1

Open in a new tab

Brain sectionalization: (A) the residual part of the olfactory bulbs, (B) optic chiasm, (C) mamillary body, (D) cerebral peduncles, (E) Pons and (F) medulla oblongata. In the sections nuclei or areas: nucleus accumbens, septal area and caudate nucleus in S2, supraoptic nucleus, paraventricular nucleus of hypothalamus, and ventromedial nucleus of hypothalamus in S4, arcuate nucleus and amygdala in S5, habenular nucleus in S6, periaqueductal gray in S8, dorsal raphe nucleus and substantia nigra in S9, parabrachial nucleus and locus ceruleus in S10, nucleus raphe magnus in S13, solitary nucleus in S14, gigantocellular reticular nucleus in S15, and spinal cord dorsal horn in S17 are located.

Twelve serial slides were chosen from near the middle of each subsection for immunohistochemical staining. Four of the twelve slides were randomly selected to detect the level of one of EOPs. Of these four slides, the three were incubated with one kind of rabbit-anti-M-ENK IgG (1 : 100), rabbit anti-β-endorphin IgG (1 : 200), or rabbit-anti-DYN-A IgG (1 : 100) (purchased from Wuhan Boster Biological Technology Ltd., Wuhan, China) while the rest was incubated with PBS instead of the corresponding antibody as negative control. Experimental procedures of SABC immunohistochemistry followed the instructions provided by the reagent company (Wuhan Boster Biological Technology Ltd., Wuhan, China). The cytoplasm of positive cells was stained as brown yellow. Optical density of the stained nuclei or area in the CNS was obtained with a light microscope connected to a video-based and computer-linked system (high-resolution pathological image analysis system-1000, Wuhan Qianping Ltd., Wuhan, China). This system was programmed to calculate the mean optical density (MOD) for three fields of each slide examined under 400× magnification. The level of EOPs in each nucleus or area was represented with the mean value ‰  of the mean optical density from the three slides.

2.5. Statistical Analysis

Statistical analysis was performed using SPSS version 18.0 (SPSS Inc., Chicago, IL, USA). All the data presented as mean ± SD. Pain threshold and EOP data were used for ANOVA followed by the Bonferroni's post hoc test. The correlation coefficient (Pearson's) was used to examine the relations between pain threshold and EOP level. Statistical significance was evaluated by determining if the P value was equal to or less than 0.05.

3. Results

3.1. Effects of EA of Different Frequencies on Pain Threshold

The analgesic effects of EA of different frequencies in goats were expressed as the pain threshold (Figure 2). After EA treatment for 30 min, the pain threshold increased as frequency increased, reached the highest at 60 Hz, but decreased at 80 Hz. Frequencies of 100, 80, 60, 40, and 2 Hz increased pain threshold by 42%, 41%, 91%, 69%, and 35% (P < 0.01), respectively. The pain threshold of goats stimulated by 60 Hz was higher (P = 0.001) than that by 40 Hz. The pain threshold by either 60 Hz or 40 Hz was higher (P = 0.001) than that by 80, 100, or 2 Hz. The pain threshold between goats in sham control and 0 Hz was no difference (P = 1.000). Because there was no difference (P = 1.000) in pain threshold between goats stimulated with 80 and 100 Hz, the effect of 80 Hz on the release of EOPs was not considered in the following experiment.

Figure 2.

Figure 2

Open in a new tab

Pain threshold of goats stimulated by different frequencies (mean ± SD, %, n = 7). The same letter indicated that no significant difference in pain threshold between two frequencies (P > 0.05), and different letter indicated significant difference (P < 0.05).

3.2. Level of M-ENK Release Induced by Different Frequencies in the CNS

The levels of M-ENK were measured in the analgesia-related nuclei or areas which included nucleus accumbens (ACB), septal area (SA), caudate nucleus (CAU), amygdala (AMY), supraoptic nucleus (SON), paraventricular nucleus of hypothalamus (PVH), ventromedial nucleus of hypothalamus (VMH), periaqueductal gray (PAG), dorsal raphe nucleus (DR), substantia nigra (SN), parabrachial nucleus (PBN), locus ceruleus (LC), nucleus raphe magnus (NRM), and spinal cord dorsal horn (SCD). The release levels of M-ENK between the sham control and 0 Hz were no differences (P > 0.05) in the measured nuclei and areas. EA of different frequencies facilitated M-ENK release significantly (P < 0.05) in the measured nuclei or areas except NRM, SON and SCD (Table 1). 60 Hz induced M-ENK immunoactivities to increase by over 100% in the measured nuclei and areas except SN, SON, NRM, and SCD, and by over 300% in SA, AMY, and PAG. 100 Hz promoted M-ENK immunoactivities to increase by over 100% in SA, AMY, PVH, VMH, PAG, PBN, and LC, and by over 300% in PBN. 2 Hz increased M-ENK immunoactivities by over 100% in AMY, PVH and PAG. As frequency increased, M-ENK immunoactivities of the forebrain nuclei, and AMY, VMH, and PAG increased, reached the highest at 60 Hz, and then decreased at 100 Hz. There was no difference in M-ENK of VMH, SN or LC between goats stimulated by 60 Hz and 40 Hz, or by 60 Hz and 100 Hz. In DR, M-ENK immunoactivities elicited by 40 or 60 Hz were higher than those by 2 Hz or 100 Hz. There was no difference in M-ENK immunoactivities between goats stimulated by 40 Hz and 60 Hz in this nucleus. In PBN, M-ENK immunoactivities induced by 100 Hz were higher than those by 40 or 2 Hz (P = 0.0001), but not higher (P = 0.663) than those by 60 Hz. In SCD, 2 Hz caused M-ENK immunoactivities to increase (P = 0.0001) while the frequency of 40, 60 or 100 Hz did not. Statistic analysis showed that the pain thresholds correlated (P < 0.01) with M-ENK immunoactivities in the measured nuclei and areas except SON, NRM, and SCD.

Table 1.

M-EMK immunoactivities induced by different frequencies in the CNS (mean ± SD, n = 7).

Nuclei
and areas		 Sham control 0 Hz 2 Hz 40 Hz 60 Hz 100 Hz Correlation coefficients
ACB 15.60 ± 1.69c 15.30 ± 2.97c 24.56 ± 2.50b 32.69 ± 3.92a 35.15 ± 4.41a 22.59 ± 2.89b 0.888**
SA 15.14 ± 1.53e 14.77 ± 2.39e 25.05 ± 1.94d 54.95 ± 3.50b 60.51 ± 4.35a 33.81 ± 3.72c 0.923**
CAU 15.00 ± 1.92c 14.35 ± 3.18c 22.78 ± 2.92b 25.24 ± 5.64b 32.66 ± 3.47a 26.88 ± 5.48b 0.724**
AMY 10.47 ± 1.58d 10.04 ± 2.43d 20.49 ± 3.28c 35.06 ± 7.69b 47.28 ± 5.56a 38.45 ± 7.97ab 0.795**
SON 33.21 ± 2.58 32.99 ± 5.03 30.54 ± 6.16 31.68 ± 8.17 31.90 ± 6.49 33.73 ± 5.61 0.071
PVH 18.22 ± 3.59b 17.95 ± 4.25c 35.01 ± 6.18b 47.38 ± 7.63a 46.70 ± 10.22a 40.76 ± 3.55ab 0.734**
VMH 11.95 ± 1.72b 11.09 ± 3.29b 18.47 ± 2.56b 36.56 ± 8.99a 40.65 ± 10.10a 38.19 ± 9.27a 0.735**
PAG 8.05 ± 0.77c 7.75 ± 1.16c 20.53 ± 3.60b 23.29 ± 4.26b 33.71 ± 6.73a 16.74 ± 2.51b 0.808**
DR 11.56 ± 1.51c 11.34 ± 4.03c 16.73 ± 2.26b 29.01 ± 2.28a 26.30 ± 2.70a 20.49 ± 3.25b 0.837**
SN 12.72 ± 2.05b 12.42 ± 2.74b 15.14 ± 3.02b 22.95 ± 1.58a 22.64 ± 5.20a 20.36 ± 1.51a 0.721**
PBN 7.69 ± 1.04c 7.18 ± 1.61c 9.71 ± 1.52c 18.90 ± 2.93b 26.44 ± 3.53a 29.13 ± 3.01a 0.656**
LC 11.69 ± 1.15c 10.93 ± 0.89c 15.68 ± 2.97b 27.49 ± 2.11a 27.80 ± 3.60a 25.15 ± 3.31a 0.799**
NRM 14.15 ± 1.39 13.77 ± 2.74 15.77 ± 1.55 15.53 ± 3.92 17.07 ± 2.27 15.76 ± 4.28 0.263
SCD 5.22 ± 0.55b 5.22 ± 0.77b 7.31 ± 0.67a 6.00 ± 0.32b 5.85 ± 0.58b 5.44 ± 0.38b 0.123
Open in a new tab

ACB: nucleus accumbens, SA: septal area, CAU: caudate nucleus, AMY: amygdala, SON: supraoptic nucleus, SN: substantia nigra, PAG: periaqueductal gray, NRM: nucleus raphe magnus, PBN: parabrachial nucleus, LC: locus ceruleus, DR: dorsal raphe nucleus, SCD: spinal cord dorsal horn, PVH: paraventricular nucleus of hypothalamus, VMH: ventromedial nucleus of hypothalamus.

Note: There was difference (P < 0.05) between the values with different letters, and no difference (P > 0.05) with the same letters in a line. *means the levels of the endogenous opioid peptides correlate with the pain thresholds at the 0.05 level, and the levels at the 0.01 level. **The letters and symbols in the following tables have the same meanings as the table above.

3.3. Level of β-EP Release Induced by Different Frequencies in the CNS

The β-EP levels were measured in the analgesia-related nuclei and areas which included ACB, SA, AMY, CAU, SON, arcuate nucleus (ARC), VMH, habenular nucleus (HB), PAG, DR, LC, PBN, NRM, solitary nucleus (SOL), and SCD. There were no differences (P > 0.05) in the β-EP immunoactivities between the sham control and 0 Hz in these nuclei and areas. 60 Hz increased β-EP immunoactivities by over 100% in the most measured nuclei and areas, and by over 300% in PAG and SOL, whereas 100 Hz increased β-EP immunoactivities by over 100% in ACB, VMH, PAG, LC, SOL, and AMY. 2 Hz increased β-EP immunoactivities by over 100% in PAG and SOL. Frequencies of 40, 60, and 100 Hz promoted β-EP immunoactivities to decrease (P < 0.05) in ARC, but to increase (P < 0.05) in the other measured nuclei or areas. The β-EP immunoactivities induced by 2 Hz were higher (P < 0.05) than those by 0 Hz in ACB, SA, SON, VMH, PAG, DR, LC, SCD, SOL, and AMY, but not in CAU, ARC, HB, PBN, and NRM. As frequency increased, EA promoted β-EP immunoactivities to change in the measured nuclei and areas except CAU, SON, ARC, HB, PBN, and AMY. In CAU, PBN, and AMY, β-EP immunoactivities induced by either 40 Hz or 60 Hz were higher (P < 0.05) than those by 2 Hz or 100 Hz. But no difference existed in β-EP immunoactivities between goats stimulated by 40 Hz and 60 Hz. In SON, there were no differences in β-EP immunoactivities between goats given with 60 Hz and 40 or 100 Hz. The pain thresholds correlated (P < 0.01) with β-EP immunoactivities in the measured nuclei and areas (Table 2).

Table 2.

β-EP immunoactivities induced by different frequencies in the CNS (mean ± SD, n = 7).

Nuclei
and areas		 Sham control 0 Hz 2 Hz 40 Hz 60 Hz 100 Hz Correlation coefficients
ACB 10.57 ± 1.48d 9.25 ± 0.44d 12.21 ± 2.00c 21.01 ± 1.80b 27.61 ± 1.91a 18.70 ± 1.21b 0.891**
CAU 20.90 ± 1.99c 20.84 ±3.87c 24.05 ± 2.99bc 36.60 ± 2.17a 36.99 ± 2.28a 26.81 ± 2.41b 0.835**
SA 21.04 ± 2.03d 20.65 ± 3.58d 29.58 ± 2.66c 42.08 ± 4.24b 49.52 ± 3.02a 31.25 ± 3.21c 0.893**
AMY 18.46 ± 2.45d 18.21 ± 3.33d 32.95 ± 4.16c 53.15 ± 2.74ab 54.59 ± 3.09a 48.86 ± 3.66b 0.840**
SON 29.31 ± 1.52c 28.88 ± 2.37c 38.18 ± 5.30b 53.13 ± 2.60a 52.68 ± 2.10a 51.25 ± 1.87a 0.783**
ARC 33.45 ± 2.11a 33.42 ± 2.34a 35.13 ± 2.02a 26.83 ± 1.13bc 23.76 ± 2.74c 28.83 ± 2.63b 0.795**
VMH 19.81 ± 2.10e 18.86 ± 1.79e 34.41 ± 2.82d 56.30 ± 3.77b 61.17 ± 2.35a 47.94 ± 1.66c 0.897**
HB 17.57 ± 2.42c 16.12 ± 1.63c 18.44 ± 1.49c 22.59 ± 2.05b 26.37 ± 1.20a 27.46 ± 1.30a 0.647**
PAG 8.40 ± 0.96d 8.22 ± 1.23d 19.04 ± 1.74c 28.82 ± 3.82b 33.70 ± 3.36a 30.18 ± 3.55ab 0.871**
DR 18.63 ± 1.83d 17.82 ± 2.34d 29.07 ± 1.94c 34.06 ± 3.09ab 38.43 ± 3.45a 31.10 ± 3.09bc 0.808**
LC 14.90 ± 2.21d 13.72 ± 2.95d 21.01 ± 2.37c 30.13 ± 2.66b 35.14 ± 2.42a 30.35 ± 1.80b 0.855**
PBN 7.65 ± 1.19b 7.54 ± 1.44b 8.69 ± 0.99b 14.07 ± 2.85a 14.92 ± 1.96a 7.99 ± 1.15b 0.790**
NRM 17.37 ± 2.20c 16.52 ± 2.23c 17.93 ± 1.21c 23.50 ± 1.65b 30.25 ± 2.91a 24.89 ± 1.76b 0.779**
SOL 11.50 ± 1.02e 11.35 ± 0.88e 23.41 ± 2.46d 33.83 ± 3.64c 49.46 ± 1.42a 43.59 ± 2.17b 0.928**
SCD 7.25 ± 1.13d 6.80 ± 0.26d 10.91 ± 1.00c 14.42 ± 1.18b 17.72 ± 1.03a 10.30 ± 1.26c 0.795**
Open in a new tab

ACB: nucleus accumbens, SA: septal area, CAU: caudate nucleus, AMY: amygdala, SON: supraoptic nucleus, ARC: arcuate nucleus, LC: locus ceruleus, PAG: periaqueductal gray, DR: dorsal raphe nucleus, PBN: parabrachial nucleus, HB: habenular nucleus, NRM: nucleus raphe, SOL: solitary nucleus, VMH: ventromedial nucleus of hypothalamus magnus, SCD: spinal cord dorsal horn.

3.4. Level of DYN-A Release Induced by Different Frequencies in the CNS

The levels of DYN-A were measured in CAU, SA, AMY, SON, PVH, VMH, PAG, PBN, gigantocellular reticular nucleus (GI), and SCD. In these nuclei and areas, DYN-A immunoactivities were no differences (P > 0.05) between the sham control and 0 Hz. DYN-A immunoactivities in the CNS increased in a frequency-dependent manner. Frequency of 40, 60, or 100 Hz promoted DYN-A to increase significantly (P < 0.05) in the CNS. The DYN-A immunoactivities induced by 100 Hz were different from those by 60 Hz in the measured nuclei and areas except VMH and GI. Statistic analysis showed that the pain thresholds correlated (P < 0.05) with DYN-A immunoactivities in the measured nuclei and areas except SCD (Table 3).

Table 3.

DYN-A immunoactivities induced by different frequencies in the CNS (mean ± SD, n = 7).

Nuclei
and areas		 Sham control 0 Hz 2 Hz 40 Hz 60 Hz 100 Hz Correlation coefficients
CAU 9.03 ± 0.57d 8.89 ± 0.27d 9.77 ± 0.34d 17.22 ± 1.05c 20.91 ± 1.81b 25.37 ± 1.14a 0.573**
SA 14.93 ± 1.29d 14.68 ± 1.11d 14.88 ± 0.97d 19.82 ± 2.00c 26.61 ± 1.30b 35.75 ± 1.58a 0.400*
AMY 10.87 ± 1.10e 10.16 ± 0.65e 13.03 ± 1.55d 17.28 ± 1.40c 24.79 ± 1.42b 31.34 ± 1.44a 0.505**
SON 20.73 ± 1.52c 20.42 ± 1.08c 21.77 ± 1.41c 38.35 ± 2.51b 38.60 ± 0.94b 43.87 ± 1.77a 0.652**
PVH 8.74 ± 0.83d 8.65 ± 0.39d 8.85 ± 0.57d 17.53 ± 1.39c 19.87 ± 1.13b 23.24 ± 1.92a 0.606**
VMH 27.01 ± 1.15c 26.36 ± 1.10c 27.70 ± 1.22c 36.01 ± 1.83b 41.10 ± 1.89a 42.54 ± 1.49a 0.671**
PAG 12.27 ± 1.27d 12.02 ± 1.28d 12.87 ± 1.12d 16.94 ± 2.05c 19.68 ± 1.90b 23.72 ± 1.52a 0.457**
PBN 9.71 ± 0.74d 9.48 ± 0.55d 9.31 ± 0.50d 16.90 ± 1.73c 19.39 ± 1.44b 24.44 ± 1.19a 0.533**
GI 10.53 ± 1.01c 10.42 ± 1.32c 10.89 ± 1.58c 14.27 ± 1.85b 19.46 ± 1.60a 20.61 ± 1.34a 0.555**
SCD 3.73 ± 0.26c 3.68 ± 0.27c 4.06 ± 0.22c 5.86 ± 0.19b 6.05 ± 0.46b 10.27 ± 0.60a 0.275
Open in a new tab

CAU: caudate nucleus, SA: septal area, AMY: amygdala, SON: supraoptic nucleus, PAG: periaqueductal gray, PBN: parabrachial nucleus, GI: gigantocellular reticular nucleus, SCD: spinal cord dorsal horn, PVH: paraventricular nucleus of hypothalamus, VMH: ventromedial nucleus of hypothalamus.

4. Discussion

4.1. The Measurement for Pain Thresholds and the Acupoint Selection for Electroacupuncture

There are a few methods to determine acupuncture-induced change in pain threshold. The tail flick response or paw withdrawal reflex by radiant heat can be used for the measurement of nociceptive threshold in rats [20, 21]. But it is not applicable for larger experimental animals (such as cattle and goats) because of their thick skin and hard hoof structure. The level of analgesia in these animals is commonly determined by scores based on an animal's response to a pinprick at a particular region [22, 23]. Obviously, this method is influenced by subjective factors. Ludbrook et al. [24] and Grant and Upton [25] measured the pain threshold in goats by using an algesimetry method based on a leg-lifting response to a subcutaneous electric stimulus. This method is not an involuntary reflex but instead a learned cognitive behavior. Additionally, it cannot be used for restrained animals. Potassium iontophoresis is a convenient and reliable experimental pain stimulus that can be presented rapidly and repeatedly with minimal loss in consistency of a subject's reported pain level [16]. In our study, potassium iontophoresis provided a tool for investigating changes in the pain thresholds of EA-treated goats.

A potent analgesic effect induced by EA depends on proper prescriptions of specific acupoints. “Zusanli” (St.36) and “Sanyinjiao” (SP.6) acupoints are commonly chosen for EA to elevate the pain threshold of the traumatic rats [26, 27]. A few sets of acupoints have been employed for EAA in ruminants. Numerous studies showed that EA at a set of Baihui, Santai, Ergen, and Sanyangluo acupoints elicited an effective analgesia in cattle [5]. Liu et al. [12] demonstrated that EA at this set of acupoints caused a potent analgesic effect in goats. In this study, we adopted this set of acupoints and obtained a similar analgesic effect as Liu did [12]. Experimental investigations showed that stimulation at different acupoints activated different nuclei and areas in rats [28–30]. However, whether acupoint specificities would change the releasing modalities of EOPs elicited by EA in the CNS of ruminants deserves to be investigated.

4.2. Distribution of Endogenous Opioid Peptides in the CNS of Goats

EOPs in the CNS include five families: enkephalins, endorphins, dynorphins, endomorphins, and orphanin FQ, of which the roles of M-ENK, β-EP and DYN-A in EA-induced analgesia were best studied. Studies showed that M-ENK was mainly found in CAU, hypothalamus, SON, PVH, VMH, midbrain, formatio reticularis mesencephali, SN, pons, and formatio reticularis medullae oblongatae [31, 32]. β-EP existed in hypothalamus, SON, ARC, parafascicular nucleus, preoptic region, interpeduncular nucleus, olfactory bulb, pons, medulla oblongata, SCD, AMY, cortex, and hippocampus [33–35]. DYN-A existed in SOL, medullary lateral reticular structure, preoptic area, periventricular nucleus, SON, ARC, SCD, hypothalamus, midbrain, and forebrain [36–38]. In the present study, higher level of β-EP was seen in ARC and SON, as had been reported elsewhere [34]. The rank order of DYN-A levels in our results was VMH > SON > PAG > GI = AMY = PBN = CAU = PVH > SCD, which was similar to reports in human and rats [39, 40]. The highest immunoactivities of M-ENK existed in SON, followed by the lower levels in ACB, CAU, PVH, SA, NRM, and SN, and the lowest levels in PAG, and AMY. These results were some different from the report by Shi et al. [41] that higher level of M-ENK existed in ACB, CAU, SON, PAG and AMY in rats. This discrepancy might be caused by species variation.

4.3. Different Frequencies Induced the Release Profile of EOPs in the CNS of Goats

The veterinary practice proved that frequencies of 40 to 100 Hz are believed to be proper for analgesia of ruminants [5]. But there is a lack of studies to specify this frequency range. In the present study, the increasing magnitude of the pain threshold in goats stimulated by 60 Hz was greater than that by the frequency of 100, 80, 40, or 2 Hz. Obviously, the analgesic effect by 60 Hz was better than that by the others. It is well documented that EOPs exhibit a frequency-dependent response in EA-produced analgesia in rats [42–44]. Low frequency (2 Hz) exerts antinociceptive effects mainly by enhancing the release of ENK and β-EP, whereas high frequency (100 Hz) produces antinociceptive effects by facilitating the release of DYN [44]. However, the release profile of goats' EOPs induced by different frequencies is not clear yet. In this study, 2 Hz and 100 Hz induced M-ENK to increase significantly in ACB, SA, CAU, AMY, PVH, PAG, DR, and LC and caused β-EP to increase significantly in ACB, SA, SON, VMH, PAG, DR, LC, SOL, and AMY. 60 Hz promoted the release of M-ENK or β-EP in the measured nuclei except in ARC. Therefore, 60 Hz activated more nuclei and areas to release M-ENK and β-EP than 2 or 100 Hz did in ruminants. EOPs participate in extensively physiological modulations. Their roles in EA-induced analgesia are verified by microinjecting EOP and its antagonist or antibody into some nuclei in rats. Levels of M-ENK in ACB [45], SA [46], CAU [47], PAG [48], or DR [48], AMY [49], and SN [50, 51] were proved to affect EA-induced analgesic effect. Either were the levels of β-EP in ACB [52], SA [46], CAU [53], PAG [54], DR [55], LC [56], NRM [56], HB [57], or ARC [58]. Our results showed that EA elevated the levels of M-ENK or β-EP in these nuclei of goats. Besides, we also found that M-ENK or β-EP immunoactivities increased in LC, PBN, VMH, SOL, SON, and PVH. It is seen that high frequencies can induce the simultaneous release of M-ENK or β-EP in a broader spectrum of nuclei in ruminants than in rats.

Role of DYN-A in EA-induced analgesia in the brain is controversial. Han and Xie [59] found that DYN-A did not produce EA-induced analgesia when it was microinjected into the cerebral ventricle of rats. Zhang et al. [60] made the opposite conclusion with DYN-A microinjection. In this study, EA induced DYN-A to increase in many analgesia-related nuclei in the CNS. The DYN-A immunoactivities induced by 100 Hz were significantly different from those by 60 Hz in the measured nuclei and areas except VMH and GI. It is shown that VMH and GI in the release of DYN-A were sensitive to both 100 Hz and 60 Hz. Whether the release of DYN-A takes part in EA analgesic modulation in the CNS of ruminants needs to be studied.

Release of DYN-A induced by 100 Hz in the SCD can produce a potent analgesic effect in rats [61]. In this study, EA of high frequencies induced DYN-A to increase in the SCD. This increase was in accordance with that of Han [61]. However, the increase in β-EP immunoactivities of the SCD and its correlation with the pain threshold values were different from the report of some studies in rats [62]. This discrepancy might be caused by the variation of the species or the studied spinal fragment. In this study, SCD samples were taken from the spinal cord adjacent to the medulla oblongata rather than the lumbar spinal cord.

Studies in rats showed that stimulation at 2 Hz and 100 Hz alternatively elicited the full release of M-ENK, β-EP, and DYN-A in the CNS, which produced a synergistic effect stronger than that at 2 Hz or 100 Hz alone [63]. Veterinary practice verifies that the mode of alternating stimulation with low and high frequencies can also induce more potent analgesic effect. However, the releasing modalities of EOPs which are induced by this stimulation mode in ruminants are worthy to be investigated.

4.4. Animal Species Variation of EA-Induced Analgesia

During the last decades, our understanding of how the brain processes acupuncture analgesia has undergone considerable development. But the major results of related researches are primarily obtained from small experimental animals such as rats, rabbits, dogs and monkeys. There are many factors which affect the EA-induced analgesic effect. Besides frequencies and acupoints, species-specificity has an important impact on EA analgesia. Studies showed that EA in combination with anesthetics led to reduce the dosage of the anesthetics in human, rat, and goat by 45%–55%, 50%–60%, and over 75%, respectively [12, 13]. Obviously, ruminants should be optimal model animals for research on the mechanisms of EA-induced analgesia. Our results showed that high frequencies motivated the simultaneous release of the three EOPs in the extensive analgesia-related nuclei and areas in the CNS, which may be conducive to explain why EA induced more potent analgesia in ruminants than in rats.

5. Conclusion

60 Hz was an optimal frequency for acupuncture-induced analgesia in goats and induced the simultaneous release of M-ENK, β-EP, and DYN-A in most of analgesia-related nuclei and areas in the CNS.

Acknowledgments

This study is supported by the funds from the National Natural Science Foundation of China (nos. 30771593 and 31072177) and by the Fundamental Research Funds for the Central Universities of China (no. 2012MBDX009).

References

  • 1.Haltrecht H. Veterinary acupuncture. Canadian Veterinary Journal. 1999;40(6):401–403. [PMC free article] [PubMed] [Google Scholar]
  • 2.Taguchi R. Acupuncture anesthesia and analgesia for clinical acute pain in Japan. Evidence-Based Complementary and Alternative Medicine. 2008;5(2):153–158. doi: 10.1093/ecam/nem056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Zhang XT, JI ZP, Huang JS. Acupuncture Studies of Acupuncture Anesthesia. Science Press; 1986. [Google Scholar]
  • 4.Inoue M, Kitakoji H, Yano T, Ishizaki N, Itoi M, Katsumi Y. Acupuncture treatment for low back pain and lower limb symptoms—the relation between acupuncture or electroacupuncture stimulation and sciatic nerve blood flow. Evidence-Based Complementary and Alternative Medicine. 2008;5(2):133–143. doi: 10.1093/ecam/nem050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Chen CL. Traditional Chinese Veterinary Medicine. Chinese Agriculture Press; 1991. [Google Scholar]
  • 6.Zhang XT, JI ZP, Huang JS. Acupuncture Studies of Acupuncture Anesthesia. Science Press; 1986. [Google Scholar]
  • 7.Han JS. Acupuncture and endorphins. Neuroscience Letters. 2004;361(1–3):258–261. doi: 10.1016/j.neulet.2003.12.019. [DOI] [PubMed] [Google Scholar]
  • 8.Zhou H, Yu HJ, Wan Y, Wang Y, Chang JK, Han JS. Endomorphin-1 mediates 2 Hz but not 100 Hz electroacupuncture analgesia in the rat. Neuroscience Letters. 1999;274(2):75–78. doi: 10.1016/s0304-3940(99)00670-9. [DOI] [PubMed] [Google Scholar]
  • 9.Han JS, Wang Q. Mobilization of specific neuropeptides by peripheral stimulation of identified frequencies. News in Physiological Sciences. 1992;7(4):176–180. [Google Scholar]
  • 10.Fei H, Sun SL, Han JS. New evidence supporting differential release of enkephalin and dynorphin by low and high frequency electro-acupuncture. Chinese Science Bulletin. 1988;33(9):703–705. [Google Scholar]
  • 11.Fei H, Xie GX, Han JS. Low and high frequency electro-acupuncture stimulations release [met5] enkephalin and dynorphin A in rat spinal cord. Chinese Science Bulletin. 1987;32(21):1496–1501. [Google Scholar]
  • 12.Liu DM, Zhou ZY, Ding Y, et al. Physiologic effects of electroacupuncture combined with intramuscular administration of xylazine to provide analgesia in goats. American Journal of Veterinary Research. 2009;70(11):1326–1332. doi: 10.2460/ajvr.70.11.1326. [DOI] [PubMed] [Google Scholar]
  • 13.Han JS. Acupuncture anesthesia versus Acupuncture-assisted anesthesia. Acupuncture Research. 1997;22(1):97–102. [Google Scholar]
  • 14.Klide AM, Kung SH. Animal Acupuncture Points. 2nd edition. Philadelphia, Pa, USA: University of Pennsylvania; 1982. (Veterinary Acupuncture). [Google Scholar]
  • 15.Ulett GA, Han S, Han JS. Electroacupuncture: mechanisms and clinical application. Biological Psychiatry. 1998;44(2):129–138. doi: 10.1016/s0006-3223(97)00394-6. [DOI] [PubMed] [Google Scholar]
  • 16.Humphries SA, Long NR, Johnson MH. Iontophoretically applied potassium ions as an experimental pain stimulus for investigating pain mechanisms. Perception and Psychophysics. 1994;56(6):637–648. doi: 10.3758/bf03208357. [DOI] [PubMed] [Google Scholar]
  • 17.Tindal JS, Knaggs GS, Turvey A. The forebrain of the goat in stereotaxic coordinates. Journal of Anatomy. 1968;103(3):457–469. [PMC free article] [PubMed] [Google Scholar]
  • 18.Tindal JS, Turvey A, Blake LA. A stereotaxic atlas of the medulla oblongata of the goat’s brain. Journal of Anatomy. 1987;155:195–202. [PMC free article] [PubMed] [Google Scholar]
  • 19.Yoshikawa T. Atlas of the Brains of Domestic Animals. Tokyo, Japan: University of Tokyo Press; 1967. [Google Scholar]
  • 20.Ren MF, Han JS. An improved tail-flick test and its application in the study of acupuncture analgesia. Acta Physiological Sinica. 1978;30(2):204–208. [Google Scholar]
  • 21.Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 1988;32(1):77–88. doi: 10.1016/0304-3959(88)90026-7. [DOI] [PubMed] [Google Scholar]
  • 22.DeRossi R, Gaspar EB, Junqueira AL, Beretta MP. A comparison of two subarachnoid α2-agonists, xylazine and clonidine, with respect to duration of antinociception, and hemodynamic effects in goats. Small Ruminant Research. 2003;47(2):103–111. [Google Scholar]
  • 23.Kinjavdekar P, Amarpal GRS, Aithal HP, Pawde AM. Physiologic and biochemical effects of subarachnoidally administered xylazine and medetomidine in goats. Small Ruminant Research. 2000;38(3):217–228. doi: 10.1016/s0921-4488(00)00161-9. [DOI] [PubMed] [Google Scholar]
  • 24.Ludbrook G, Grant C, Upton R, Penhall C. A method for frequent measurement of sedation and analgesia in sheep using the response to a ramped electrical stimulus. Journal of Pharmacological and Toxicological Methods. 1995;33(1):17–22. doi: 10.1016/1056-8719(94)00051-5. [DOI] [PubMed] [Google Scholar]
  • 25.Grant C, Upton RN. The anti-nociceptive efficacy of low dose intramuscular xylazine in lambs. Research in Veterinary Science. 2001;70(1):47–50. doi: 10.1053/rvsc.2000.0439. [DOI] [PubMed] [Google Scholar]
  • 26.Zhang D, Ding GH, Shen XY, et al. Influence of mast cell function on the analgesic effect of acupuncture of “Zusanli” (ST 36) in rats. Acupuncture research. 2007;32(3):147–152. [PubMed] [Google Scholar]
  • 27.Senna-Fernandes V, França DLM, De Souza D, et al. Acupuncture at “zusanli” (St.36) and “sanyinjiao” (SP.6) points on the gastrointestinal tract: a study of the bioavailability of 99mTc-sodium pertechnetate in rats. Evidence-based Complementary and Alternative Medicine. 2011;2011 doi: 10.1093/ecam/nep009.823941 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Du SS, Du GL, Wang YQ, Liu M, Bai Y, Guan ZL. Distribution of fos-Li neurons in the spinal trigeminal nucleus after stimulation at acupoints yifeng and fengchi in rats. " Journal of Shanghai University of Traditional Chinese Medicine. 2012;26(2):78–82. [Google Scholar]
  • 29.Yan LP, Ji LX, Wang HJ, et al. Effects of “weibingfang” stimulated by electroacupuncture on expression of c-fos protein in medulla oblongata and hypothalamus of rats with acute gastric mucosal damage. Journal of Shanxi College of Traditional Chinese Medicine. 2010;11(5):9–11. [Google Scholar]
  • 30.Qin M, Huang YX, Wang JJ, Duan L, Cao R, Rao ZR. Effects of acupuncture at Tsusanli (He-Sea Point) on expression of FOS and GFAP in medullary visceral zone of rats under stress. Medical Journal of ChineSe People’S Liberation Army. 2005;30(9):819–821. [Google Scholar]
  • 31.Gramsch C, Hoellt V, Mehraein P. Regional distribution of methione-enkephalin- and beta-endorphin-like immunoreactivity in human brain and pituitary. Brain Research. 1979;171(2):261–270. doi: 10.1016/0006-8993(79)90332-9. [DOI] [PubMed] [Google Scholar]
  • 32.Khachaturian H, Lewis ME, Watson SJ. Enkephalin systems in diencephalon and brainstem of the rat. Journal of Comparative Neurology. 1983;220(3):310–320. doi: 10.1002/cne.902200305. [DOI] [PubMed] [Google Scholar]
  • 33.Bloom F, Battenberg E, Rossier J. Neurons containing β-endorphin in rat brain exist separately from those containing enkephalin: immunocytochemical studies. Proceedings of the National Academy of Sciences of the United States of America. 1978;75(3):1591–1595. doi: 10.1073/pnas.75.3.1591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Akil H, Watson SJ, Young E. Endogenous opioids: biology and function. Annual Review of Neuroscience. 1984;7:223–255. doi: 10.1146/annurev.ne.07.030184.001255. [DOI] [PubMed] [Google Scholar]
  • 35.Karuri AR, Ayres S, Kumar MSA. Regional distribution of gonadotropin-releasing hormone-like, β-endorphin-like, and methionine-enkephalin-like immunoreactivities in the central nervous system of the goat. Brain Research Bulletin. 2000;51(1):63–68. doi: 10.1016/s0361-9230(99)00205-1. [DOI] [PubMed] [Google Scholar]
  • 36.Weber E, Barchas JD. Immunohistochemical distribution of dynorphin B in rat brain: relation to dynorphin A and α-neo-endorphin systems. Proceedings of the National Academy of Sciences of the United States of America. 1983;80(4):1125–1129. doi: 10.1073/pnas.80.4.1125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Xiang ZH, Gu GQ. The morphology and distribution of DYN A 1-13 neuron in the rat hypothalamus. Chinese Journal of Anatomy. 1991;14(4):304–307. [Google Scholar]
  • 38.Han JS, Wang Q. Arcuate nucleus (ARH) and parabrachial nucleus (PBN) mediate low-and high-frequency electroacupuncture analgesia. Acupuncture Research. 1991;8(4):181–182. [Google Scholar]
  • 39.Gramsch C, Hoellt V, Pasi A. Immunoreactive dynorphin in human brain and pituitary. Brain Research. 1982;233(1):65–74. doi: 10.1016/0006-8993(82)90930-1. [DOI] [PubMed] [Google Scholar]
  • 40.Höllt V, Haarmann I, Bovermann K, Jerlicz M, Herz A. Dynorphin-related immunoreactive peptides in rat brain and pituitary. Neuroscience Letters. 1980;18(2):149–153. doi: 10.1016/0304-3940(80)90318-3. [DOI] [PubMed] [Google Scholar]
  • 41.Shi YL, Zhang JP, Bai WZ. The research progress of enkephalin. Journal of Hebei Medical University. 2007;28(2):148–150. [Google Scholar]
  • 42.Zhao ZQ. Neural mechanism underlying acupuncture analgesia. Progress in Neurobiology. 2008;85(4):355–375. doi: 10.1016/j.pneurobio.2008.05.004. [DOI] [PubMed] [Google Scholar]
  • 43.Cho ZH, Hwang SC, Wong EK, et al. Neural substrates, experimental evidences and functional hypothesis of acupuncture mechanisms. Acta Neurologica Scandinavica. 2006;113(6):370–377. doi: 10.1111/j.1600-0404.2006.00600.x. [DOI] [PubMed] [Google Scholar]
  • 44.Han JS. Acupuncture: neuropeptide release produced by electrical stimulation of different frequencies. Trends in Neurosciences. 2003;26(1):17–22. doi: 10.1016/s0166-2236(02)00006-1. [DOI] [PubMed] [Google Scholar]
  • 45.Jin WQ, Zhou ZF, Han JS. Inhibition of enkephalins degradation in nucleus accumbens leads to potentiation of acupuncture and morphine analgesia. Acta Physiologica Sinica. 1985;37(4):377–382. [PubMed] [Google Scholar]
  • 46.Mo HY, Ou SP, Qiu YF. Inhibitory effect of septal stimulation on cortical potentials evoked by tooth pulp stimulation in rabbits and its relationship with naloxone and acupuncture analgesia. Acta Academiae Medicinae Primae Shanghai. 1983;10(6):463–468. [Google Scholar]
  • 47.Xie CW, Zhang WQ, Hong XJ, Han JS. Relation between the content of central met-enkephalin and leu-enkephalin and the analgesic effect of electroacupuncture in rats. Acta Physiologica Sinica. 1984;36(2):192–197. [Google Scholar]
  • 48.Zhao JC, Zhu " DN. The further analysis of the acupuncture analgesic role in Dorsal raphe nucleus and its adjacent gray region. Shaanxi Medical Journal. 1980;9(12):44–47. [Google Scholar]
  • 49.Xu DY, Zhou ZF, Han JS. Amygdaloid serotonin and endogenous opioid substances (OLS) are important for mediating electroacupuncture analgesia and morphine analgesia in the rabbit. Acta Physiologica Sinica. 1985;37(2):162–171. [PubMed] [Google Scholar]
  • 50.Baumeister AA, Anticich TG, Hawkins MF, Liter JC, Thibodeaux HF, Guillory EC. Evidence that the substantia nigra is a component of the endogenous pain suppression system in the rat. Brain Research. 1988;447(1):116–121. doi: 10.1016/0006-8993(88)90971-7. [DOI] [PubMed] [Google Scholar]
  • 51.Sun DY, Wang WQ, Gao DM, Lu ZQ. Influences of intranigral injection of kainic acid on electroacupuncture analgesia and morphine analgesia in the rabbits. Acupuncture research. 1986;11(2):113–118. [PubMed] [Google Scholar]
  • 52.Ma QP, Shi YS, Han JS. Periaqueductal gray and nucleus Accumbens influence each other to promote the release of enkephalin and β-endorphin in rabbit brain. Chinese Science Bulletin. 1991;11:855–858. [Google Scholar]
  • 53.He LF, Du LN, Zhang XG, Shi ZZ, Jiang JW. Effect of intracaudate microinjection of naloxone on electroacupuncture analgesia. Acta Academic Medicine Prima Shanghai. 1980;7(5):332–337. [Google Scholar]
  • 54.Xie GX, Zhou ZF, Han JS. Electro-acupuncture analgesia in the rabbit was partially blocked by anti-β-endorphin antiserum injected into periaqueductal grey, but not by its intrathecal injection. Acupuncture Research. 1981;(4):275–280. [Google Scholar]
  • 55.Chen XY, Yin WP, Yin QZ. The dorsal raphe nucleus is involved in the inhibitory effect of hypothalamic arcuate stimulation on pain-evoked unit discharges of the thalamic parafascicular nucleus. Acta Physiologica Sinica. 1987;39(1):46–53. [PubMed] [Google Scholar]
  • 56.You ZD, Song CY, Wang CH, Lin BC. Effect of stimulating the supraoptic nucleus and EIectroacupuncture on β-endorphin contents in locus ceruleus and nucleus raphe magnus in rats. Acupuncture Research. 1994;19(3):40–41. [Google Scholar]
  • 57.Xuan YT, Zhou ZF, Wu WY, Han JS. Antagonism of acupuncture analgesia and morphine analgesia by microinjection of cinanserin into nucleus accumbens or habenula in the rabbit. Journal of Beijing Medical College. 1982;14(1):23–26. [Google Scholar]
  • 58.Chen QL, Liu HC, Gu F, Yin QZ. Effects of neonatal administration of monosodium glutamate on acupuncture analgesia and beta-endorphin-immunoreactive neurons in the rat hypothalamic arcuate nucleus. Acupuncture Research. 1987;12(3):235–238. [PubMed] [Google Scholar]
  • 59.Han JS, Xie CW. Dynorphin: potent analgesic effect in spinal cord of the rat. Life Sciences. 1982;31(16-17):1781–1784. doi: 10.1016/0024-3205(82)90209-0. [DOI] [PubMed] [Google Scholar]
  • 60.Zhang W, Tian JH, Han JS. Analgesic effect of dynorphin A (1∼13) and its antagonistic effect on morphine analgesia in rat brain in the cold water tail flick test assay. Chinese Journal of Neuroscience. 1999;15(2):120–124. [Google Scholar]
  • 61.Han JS, Chen XH, Sun SL, et al. Effect of low- and high-frequency TENS on Met-enkephalin-Arg-Phe and dynorphin A immunoreactivity in human lumbar CSF. Pain. 1991;47(3):295–298. doi: 10.1016/0304-3959(91)90218-M. [DOI] [PubMed] [Google Scholar]
  • 62.Xie GX, Zhou ZF, Han JS. Acupuncture analgesic effects of microinjection of enkephalin, β-endorphin and substance P antibodies into the CNS. Acta Physiologica Sinica. 1982;2(1):10–11. [Google Scholar]
  • 63.Chen XH, Guo SF, Chang CG, Han JS. Optimal conditions for eliciting maximal electroacupuncture analgesia with dense-and-disperse mode stimulation. American Journal of Acupuncture. 1994;22(1):47–53. [Google Scholar]

Articles from Evidence-based Complementary and Alternative Medicine : eCAM are provided here courtesy of Wiley

RESOURCES